{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T13:16:58Z","timestamp":1768655818289,"version":"3.49.0"},"reference-count":31,"publisher":"Japanese Society of Toxicologic Pathology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1293\/tox.2025-0016","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T22:07:58Z","timestamp":1756332478000},"page":"15-23","source":"Crossref","is-referenced-by-count":0,"title":["Association between spontaneous neurogenic atrophy of the femoral muscle and islet cell tumors in aged F344 rats"],"prefix":"10.1293","volume":"39","author":[{"given":"Mitsutoshi","family":"Uchida","sequence":"first","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Wako","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Shimoyama","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Pathology Group, Research UnitII, Drug Discovery Innovation Center, Non-Clinical Business Segment, Mediford Corporation, 1285 Kurizaki-machi, Uto, Kumamoto 869-0425, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Doi","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Tomonari","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Sato","sequence":"additional","affiliation":[{"name":"Kashima Pathology Group, Pathology Department, Drug Discovery Regulatory Center, Non-clinical Business Segment, Mediford Corporation, Kamisu-shi, Ibaraki 314-0255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Br\u00e4ndli-Baiocco A, Balme E, Bruder M, Chandra S, Hellmann J, Hoenerhoff MJ, Kambara T, Landes C, Lenz B, Mense M, Rittinghausen S, Satoh H, Schorsch F, Seeliger F, Tanaka T, Tsuchitani M, Wojcinski Z, and Rosol TJ. Nonproliferative and proliferative lesions of the rat and mouse endocrine system. J Toxicol Pathol. 31(Suppl): 1S\u201395S. 2018.","DOI":"10.1293\/tox.31.1S"},{"key":"2","unstructured":"2.  NTP. NTP Historical Controls Report: All Routes and Vehicles: Rats. 29\u201330. 2009, from U.S. Department of Health and Human Services, National Toxicology Program website: https:\/\/ntp.niehs.nih.gov\/data\/controls."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Di Girolamo N, and Selleri P. Medical and surgical emergencies in ferrets. Vet Clin North Am Exot Anim Pract. 19: 431\u2013464. 2016.","DOI":"10.1016\/j.cvex.2016.01.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Krinke GJ. Spontaneous radiculoneuropathy, Aged Rats. In: Nervous System. TC Jones, U Mohr, and RD Hunt (eds). Springer Berlin, Heidelberg: 203\u2013208. 1988.","DOI":"10.1007\/978-3-642-83516-2_35"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Greaves P. Musculoskeletal system. In: Histopathology of Preclinical Toxicity Studies Interpretation and Relevance in Drug Safety Evaluation, 4th ed. Academic Press, London. 192. 2012.","DOI":"10.1016\/B978-0-444-53856-7.00005-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Sugimoto K, Baba M, Suda T, Yasujima M, and Yagihashi S. Peripheral neuropathy and microangiopathy in rats with insulinoma: association with chronic hyperinsulinemia. Diabetes Metab Res Rev. 19: 392\u2013400. 2003.","DOI":"10.1002\/dmrr.395"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Jensen VFH, M\u00f8lck AM, Berthelsen LO, Alifrangis L, Andersen L, Chapman M, Lykkesfeldt J, and B\u00f8gh IB. Toxicological effects during and following persistent insulin-induced hypoglycaemia in healthy euglycaemic rats. Basic Clin Pharmacol Toxicol. 121: 53\u201366. 2017.","DOI":"10.1111\/bcpt.12769"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Jensen VFH, Molck AM, Soeborg H, Nowak J, Chapman M, Lykkesfeldt J, and Bogh IB. Proximal neuropathy and associated skeletal muscle changes resembling denervation atrophy in hindlimbs of chronic hypoglycaemic rats. Basic Clin Pharmacol Toxicol. 122: 165\u2013175. 2018.","DOI":"10.1111\/bcpt.12870"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Germann P-G, Heinrichs M, P\u00fcschner H, Hellmann J, Kohler M, and Ernst H. RITA\/Registry of Industrial Toxicology Animal data: a comparative immunohistochemical study of 77 islet cell carcinomas in Sprague-Dawley and Wistar rats using antibodies against insulin, glucagon, somatostatin and gastrin. Exp Toxicol Pathol. 51: 477\u2013487. 1999.","DOI":"10.1016\/S0940-2993(99)80119-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Koivisto C, Flake GP, Kolenda-Roberts H, Masinde T, Kissling GE, Sills RC, and Hoenerhoff MJ. Immunohistochemical investigation of F344\/N rat islet cell tumors from national toxicology program studies. Toxicol Pathol. 40: 751\u2013763. 2012.","DOI":"10.1177\/0192623312441407"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.  Behan WMH, Cossar DW, Madden HA, and McKay IC. Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle. J Clin Pathol. 55: 375\u2013380. 2002.","DOI":"10.1136\/jcp.55.5.375"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.  Brooke MH, Williamson E, and Kaiser KK. The behavior of four fiber types in developing and reinnervated muscle. Arch Neurol. 25: 360\u2013366. 1971.","DOI":"10.1001\/archneur.1971.00490040086010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Greaves P, Chouinard L, Ernst H, Mecklenburg L, Pruimboom-Brees IM, Rinke M, Rittinghausen S, Thibault S, Von Erichsen J, and Yoshida T. Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium. J Toxicol Pathol. 26(Suppl): 1S\u201326S. 2013.","DOI":"10.1293\/tox.26.1S"},{"key":"14","unstructured":"14.  Vahle JL, Leininger JR, Long PH, Hall DG, Ernst H. Bone, muscle, and tooth. In: Toxicologic Pathology Nonclinical Safety Assessment, 2nd ed. PS Sahota, JA Popp, JF Hardisty, C Gopinath, and PR Bouchard (eds). CRC Press, Boca Raton. 731\u2013732. 2019."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15.  Bevere M, Gkountakos A, Martelli FM, Scarpa A, Luchini C, and Simbolo M. An insight on functioning pancreatic neuroendocrine neoplasms. Biomedicines. 11: 303. 2023.","DOI":"10.3390\/biomedicines11020303"},{"key":"16","unstructured":"16.  Giannis D, Moris D, Karachaliou GS, Tsilimigras DI, Karaolanis G, Papalampros A, and Felekouras E. Insulinomas: from diagnosis to treatment. A review of the literature. JBUON. 25: 1302\u20131314. 2020."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Heckmann JG, Dietrich W, Hohenberger W, Klein P, Hanke B, and Neund\u00f6rfer B. Hypoglycemic sensorimotor polyneuropathy associated with insulinoma. Muscle Nerve. 23: 1891\u20131894. 2000.","DOI":"10.1002\/1097-4598(200012)23:12<1891::AID-MUS17>3.0.CO;2-Y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.  Jaspan JB, Wollman RL, Bernstein L, and Rubenstein AH. Hypoglycemic peripheral neuropathy in association with insulinoma: implication of glucopenia rather than hyperinsulinism. Case report and literature review. Medicine (Baltimore). 61: 33\u201344. 1982.","DOI":"10.1097\/00005792-198201000-00004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Tintor\u00e9 M, Montalb\u00e1n J, Cervera C, Codina A, Royo I, Crespo J, and Navarro C. Peripheral neuropathy in association with insulinoma: clinical features and neuropathology of a new case. J Neurol Neurosurg Psychiatry. 57: 1009\u20131010. 1994.","DOI":"10.1136\/jnnp.57.8.1009"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Schoemaker NJ. Ferret oncology. Vet Clin North Am Exot Anim Pract. 20: 183\u2013208. 2017.","DOI":"10.1016\/j.cvex.2016.07.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Godlewska A, Barszcz K, Orzechowska A, and Ma\u0142ek-Sanig\u00f3rska A. New insight on insulinoma treatment in a pet rat-a case report. Animals (Basel). 12: 2783. 2022.","DOI":"10.3390\/ani12202783"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.  Robertson J, Brand\u00e3o J, Blas-Machado U, Cohen E, and Mayer J. Spontaneous pancreatic islet cell adenoma with peripheral neuropathy in a pet rat (rattus norvegicus). J Exot Pet Med. 28: 166\u2013172. 2019.","DOI":"10.1053\/j.jepm.2018.10.003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.  Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO, Rahman MA, Hannan MA, Uddin MJ, and Pang MG. Role of insulin in health and disease: an update. Int J Mol Sci. 22: 6403. 2021.","DOI":"10.3390\/ijms22126403"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  Jensen VFH, B\u00f8gh IB, and Lykkesfeldt J. Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies. J Neuroendocrinol. 26: 123\u2013150. 2014.","DOI":"10.1111\/jne.12133"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.  Mohseni S. Hypoglycemic neuropathy. Acta Neuropathol. 102: 413\u2013421. 2001.","DOI":"10.1007\/s004010100459"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.  Fujiwara S, Yamaguchi Y, Saito T, Nakazawa T, and Tamura K. Spontaneous well-differentiated pancreatic islet cell carcinoma with vascular invasion in a male F344 rat. J Toxicol Pathol. 35: 99\u2013102. 2022.","DOI":"10.1293\/tox.2021-0037"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.  Stromberg PC, Wilson F, and Capen CC. Immunocytochemical demonstration of insulin in spontaneous pancreatic islet cell tumors of Fischer rats. Vet Pathol. 20: 291\u2013297. 1983.","DOI":"10.1177\/030098588302000305"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28.  Portela-Gomes GM, Hacker GW, and Weitgasser R. Neuroendocrine cell markers for pancreatic islets and tumors. Appl Immunohistochem Mol Morphol. 12: 183\u2013192. 2004.","DOI":"10.1097\/00129039-200409000-00001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.  Komminoth P, Heitz PU, and Roth J. Human insulinoma: clinical, cellular, and molecular aspects. Endocr Pathol. 10: 269\u2013281. 1999.","DOI":"10.1007\/BF02739769"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30.  Tomita T. Immunocytochemical localization of prohormone convertase 1\/3 and 2 in pancreatic islet cells and islet cell tumors. Pancreas. 23: 172\u2013176. 2001.","DOI":"10.1097\/00006676-200108000-00007"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31.  Kimura N, Pilichowska M, Okamoto H, Kimura I, and Aunis D. Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol. 13: 140\u2013146. 2000.","DOI":"10.1038\/modpathol.3880026"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/39\/1\/39_2025-0016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:39:42Z","timestamp":1768624782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/39\/1\/39_2025-0016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2025-0016","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025-0016"}}